(E)-N-((3R,3aR,3a1S,9R,9aS)-9-(N-(cyclopropylmethyl)phenylsulfonamido)-9a-hydroxy-5-methoxy-1,2,3,3a,3a1,8,9,9a-octahydrophenanthro[4,5-bcd]furan-3-yl)-3-(furan-3-yl)-N-methylacrylamide

ID: ALA4523024

PubChem CID: 155543728

Max Phase: Preclinical

Molecular Formula: C33H36N2O7S

Molecular Weight: 604.73

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2c3c1O[C@H]1[C@H](N(C)C(=O)/C=C/c4ccoc4)CC[C@](O)([C@@H]31)[C@H](N(CC1CC1)S(=O)(=O)c1ccccc1)C2

Standard InChI:  InChI=1S/C33H36N2O7S/c1-34(28(36)13-10-22-15-17-41-20-22)25-14-16-33(37)27(18-23-11-12-26(40-2)32-29(23)30(33)31(25)42-32)35(19-21-8-9-21)43(38,39)24-6-4-3-5-7-24/h3-7,10-13,15,17,20-21,25,27,30-31,37H,8-9,14,16,18-19H2,1-2H3/b13-10+/t25-,27-,30+,31+,33-/m1/s1

Standard InChI Key:  RPOAEJZHJXDZID-QFPXGXDBSA-N

Molfile:  

 
     RDKit          2D

 45 51  0  0  0  0  0  0  0  0999 V2000
    3.3513   -2.5548    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9468   -3.2646    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.7639   -3.2600    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0732   -4.4533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3757   -4.0509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0756   -5.2622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7600   -4.0593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7648   -5.6521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2462   -4.8918    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6765   -4.4825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3805   -5.6562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6788   -5.2664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3733   -3.2421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7701   -3.2504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7672   -6.4610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3829   -6.4651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0684   -2.8355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0805   -6.8716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4898   -6.8758    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4727   -2.8556    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9622   -4.0854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2612   -4.5054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2348   -2.8712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3707   -4.8660    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2242   -2.0595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5129   -1.6662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8152   -2.0863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8333   -2.9038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5450   -3.2934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2745   -5.3225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8800   -6.0377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6971   -6.0245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1756   -3.2724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8880   -2.8721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5909   -3.2890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3033   -2.8887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4822   -2.0385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1660   -4.0896    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0452   -3.2299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5990   -2.6290    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1987   -1.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3975   -2.0772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4632   -3.6443    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.0682   -3.6361    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    6.4918   -7.6929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  5  4  1  0
  4  6  1  0
  7  4  1  0
  8  6  2  0
  9  7  1  0
 10  5  1  0
 11  6  1  0
 12 11  1  0
 13  5  1  0
 14  7  1  0
 15  8  1  0
 16 11  2  0
 17 14  1  0
 18 16  1  0
 19 15  1  0
  8  9  1  0
 17 13  1  0
 12 10  1  0
 18 15  2  0
 14 20  1  1
 10 21  1  1
 21  2  1  0
 21 22  1  0
  2 23  1  0
  5 24  1  1
 23 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 23  1  0
 22 30  1  0
 31 30  1  0
 32 31  1  0
 30 32  1  0
 20 33  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 20 37  1  0
 33 38  2  0
 36 39  2  0
 39 40  1  0
 40 41  1  0
 41 42  2  0
 42 36  1  0
  7 43  1  1
  4 44  1  1
 19 45  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4523024

    ---

Associated Targets(Human)

HCRTR2 Tclin Orexin receptor 2 (5902 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCRTR1 Tclin Orexin receptor 1 (5435 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 604.73Molecular Weight (Monoisotopic): 604.2243AlogP: 4.22#Rotatable Bonds: 9
Polar Surface Area: 109.52Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.70CX Basic pKa: CX LogP: 3.66CX LogD: 3.66
Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.36Np Likeness Score: 0.34

References

1. Saitoh T, Seki K, Nakajima R, Yamamoto N, Kutsumura N, Nagumo Y, Irukayama-Tomobe Y, Ogawa Y, Ishikawa Y, Tanimura R, Yanagisawa M, Nagase H..  (2019)  Essential structure of orexin 1 receptor antagonist YNT-707, Part IV: The role of D-ring in 4,5-epoxymorphinan on the orexin 1 receptor antagonistic activity.,  29  (18): [PMID:31375290] [10.1016/j.bmcl.2019.07.039]

Source